|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 18, 2013 ) New York, NY -- Gynecomastia or man boobs is known to be a highly embarrassing problem among men. Typically, it is abnormal growth of breasts in men. Though a large percentage of teenagers are known to be affected with this problem, most of the time problem gets cured on its own. However, the problem persists in adulthood in a small percentage of men.
“Gynexols is a new formula that has been developed after a lot of research and it is known to be clinically proven to help men with reducing man boobs without undergoing a surgeon’s knife” says a MenAndLibido.com spokesperson.
Listed below are some of the key points highlighted in Gynexol Review done by the popular men’s health site MenAndLibido.com:
- Natural formulation that is easy to use and apply
- Made in a FDA approved lab in the US
- Clinically proven to be effective in 99% of cases
- Pain free method to get rid of man boobs
- No known side effects
- Great customer support
- A large base of satisfied and happy clients
- Money back guarantee
- Worldwide and discreet delivery
“Gynexol is a very easy to use formula. Most men find it easy to use as compared to pills and other procedures. It is a highly recommended product for men who want to get a flatter and more masculine chest. There are no known side effects and can save you a lot of embarrassment. However, it is needs time to produce effects. Unlike surgery that can ensure immediate effects, Gynexol must be used for at least 4-5 months to get the best results” says a MenAndLibido.com spokesperson.
To find out more on Gynexol, visit http://menandlibido.com/gynexol-reduce-man-boobs
About MenAndLibido.com:
MenAndLibido.com is a health and fitness site for men that covers all health related topics concerning men. It is also known for its unbiased reviews of the latest health products and supplements in the market to help men take well educated and informed buying decisions.
MenandLibido.com
Paul Norman
0911164455576
tanquraishi1@gmail.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
